Clay Siegall, the Chief Executive Officer, President, and the Chairman of the Board of Directors of Seattle Genetics is an American citizen who focuses on making the lives of other citizens better. Clay Siegall went to the University of Maryland and obtained a Bachelor degree in Zoology, and later went to George Washington University for a P.H.D in genetics. It is with the academic background that he gained sound knowledge regarding genetics and health issues. He also focuses on helping people living with cancer.
In the year 1991, Clay Siegall joined Bristol-Myers Squibb Pharmaceutical Research institution where he worked until 1997. He also worked with National Institute of Health between 1998 and 1991. Clay Siegall also worked for National Cancer Institute and is also one of the Board of Directors of Mirna Therapeutic and Alder Biopharmaceutical. Clay Siegall Got a lot of exposure into his career from the work experience he had got from the previous positions, and it’s from this that he became a professional doctor. Clay Siegall is also a well-known entrepreneur, and in 2012 he was awarded as the best entrepreneur of the year at Pacific Northwest.
Clay Siegall has contributed greatly to cancer awareness and treatment. He created cancer treatments using antibodies, and this is the reason why he decided to open his company. He made Seattle Genetic a great place where people would go whenever they are in need of trying any new medication. Dr. Clay always aims at offering more drugs to his patients and has also created a plan where he will provide over twelve new drugs to the community. Dr. Clay Siegall plans is to help people who are in need of a new cancer medication that only his company can provide. He hopes to save more people living with cancer as he is capable of helping.